Sheina Emrani
Overview
Explore the profile of Sheina Emrani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
1088
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Emrani S, Koutures A, Tripodis Y, Uretsky M, Abdolmohammadi B, Nowinski C, et al.
Acta Neuropathol
. 2025 Mar;
149(1):24.
PMID: 40047953
Chronic traumatic encephalopathy (CTE) is a progressive brain disease linked to repetitive head impacts (RHI), often incurred from contact sports, and can lead to dementia. Here, we investigated the association...
2.
Emrani S, Sundermann E
Front Neuroendocrinol
. 2025 Feb;
77:101184.
PMID: 39951912
The two-times higher prevalence of Alzheimer's disease (AD) in females versus males is well-known; however, there are also sex/gender differences in clinical presentation and diagnostic accuracy that are less examined...
3.
Matyi M, Rhodes E, Emrani S, Jin H, Irwin D, McMillan C, et al.
medRxiv
. 2025 Jan;
PMID: 39830261
Racial disparities in neuropsychological test performance are well documented in Alzheimer's Disease (AD) but have received little attention in frontotemporal degeneration (FTD). Identification of potential disparities in neuropsychological performance is...
4.
APOE ε4-associated heterogeneity of neuroimaging biomarkers across the Alzheimer's disease continuum
Mares J, Kumar G, Sharma A, Emrani S, McIntire L, Guo J, et al.
Alzheimers Dement
. 2024 Nov;
21(1):e14392.
PMID: 39575672
Introduction: While the role of apolipoprotein E (APOE) ε4 in Alzheimer's disease (AD) susceptibility has been studied extensively, much less is known about the differences in disease presentation in APOE...
5.
Thompson L, De Vito A, Kunicki Z, Emrani S, Strenger J, Nester C, et al.
J Int Neuropsychol Soc
. 2024 Sep;
30(8):785-793.
PMID: 39301587
Objective: The psychometric rigor of unsupervised, smartphone-based assessments and factors that impact remote protocol engagement is critical to evaluate prior to the use of such methods in clinical contexts. We...
6.
Howe M, Caruso M, Manoochehri M, Kunicki Z, Emrani S, Rudolph J, et al.
Alzheimers Dement
. 2024 Sep;
20(10):7220-7231.
PMID: 39219209
Introduction: The relationship between cerebrovascular disease (CVD) and amyloid beta (Aβ) in Alzheimer's disease (AD) is understudied. We hypothesized that magnetic resonance imaging (MRI)-based CVD biomarkers-including cerebral microbleeds (CMBs), lacunar...
7.
Bozzay M, Joyce H, Jiang L, De Vito A, Emrani S, Browne J, et al.
J Alzheimers Dis
. 2024 Jul;
100(3):899-909.
PMID: 38995783
Background: Older adults with heart failure are at elevated risk of Alzheimer's disease and related dementias (AD/ADRD). Research suggests that insomnia and depressive episodes contribute somewhat dissociable impacts on risk...
8.
Howe M, Britton K, Joyce H, Menard W, Emrani S, Kunicki Z, et al.
Alzheimers Res Ther
. 2024 Jul;
16(1):154.
PMID: 38971815
Background: With the approval of disease-modifying treatments (DMTs) for early Alzheimer's disease (AD), there is an increased need for efficient and non-invasive detection methods for cerebral amyloid-β (Aβ) pathology. Current...
9.
De Vito A, Emrani S, Correia S, Coutinho M, Lee A
Aging Ment Health
. 2024 Jul;
29(1):87-94.
PMID: 38952264
Objectives: The current study aimed to evaluate the relationship between subjective cognitive complaints (SCC) and compensatory strategy (CS) use in a diverse sample of non-Latinx White (NLW), Black, and Latinx...
10.
Howe M, Caruso M, Manoochehri M, Kunicki Z, Emrani S, Rudolph J, et al.
medRxiv
. 2024 Jun;
PMID: 38853879
Introduction: The relationship between cerebrovascular disease (CVD) and amyloid-β (Aβ) in Alzheimer disease (AD) is understudied. We hypothesized that magnetic resonance imaging (MRI)-based CVD biomarkers, including cerebral microbleeds (CMBs), ischemic...